A frameshift at L333 is reportedly a risk factor for AD (Figure 2A), and thus the binding of the SHARPIN NZF to the ubiquitin chain may also be required to prevent AD (Asanomi et al., 2022). Here, SHARPIN is linked to Alzheimer disease.